Mydecine: Psilocybin Sciences
Listen now
Description
Today we have the pleasure of speaking with Josh Bartch, the CEO of Mydecine, a research & development company with a special interest in psilocybin and psychoactive treatments. We discuss the origins of their work, their team, and current research and practices in the field. Topics covered: Mydecine's mission and commitment to human benefit via fungal discoveryPsilocybin treatment for PTSD and other mental health concernsMachine-learning based drug discoveryFormulation and commercialization of psychedelic therapeutics The deficiencies in chemical compounds in psilocybe mushroomsVarietals of psilocybin-containing mushrooms Collaborative and intern opportunities at Mydecine’s facilitiesDescribing new compounds in functional mushroomsBureaucracy of importing and researching psychedelic mushrooms Bioavailability of psilocybin Managing ethical clinical researchShow notes: Mydecine website: https://www.mydecine.com/Josh Bartch LinkedIn: https://www.linkedin.com/in/josh-bartch-a5361b96MindLeap app: https://mindleap.health/
More Episodes
Published 03/27/24
Today we travel to New Zealand with Liv Sisson to talk about the fungi of Aotearoa better known as New Zealand. We chat about the folklore and indigenous uses of various mushrooms and her newest book all about the topic. Sign up for our podcast giveaway here. Our next winner will be selected on...
Published 03/27/24
Today we sit down with the musician and biologist Tarun Nayar to dive into the mystical world of mushroom music. Did you know we can hook up sensors to mushrooms and turn their electrical signals into music? Learn how to make your own and sit back to listen to a track Tarun created himself with...
Published 03/14/24